OnKure Therapeutics, Inc. (OKUR) Form 8-K — Jun 4, 2026
OnKure Therapeutics (OKUR) held its 2026 Annual Meeting of Stockholders on June 3, 2026, where shareholders approved the Amended and Restated 2024 Equity Incentive Plan. The amendment increases the share reserve by approximately 3.2 million shares (8% of outstanding) and removes the previous hard cap on the annual evergreen provision, allowing the reserve to increase by 5% of outstanding shares annually without limit. The board elected R. Michael Carruthers, Valerie M.
Key figures
- Iso cap
- 8000000
- Director fee cap
- 750000
- Evergreen percentage
- 5%
- Evergreen cap removed
- Yes
- Shares reserved increase
- 3231638
- Shares reserved total base
- 5711638
- Director fee cap initial year
- 1000000
Price after filing
Close on the filing date to close N calendar days later (from $4.30). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.